Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ANGN - Angion Biomedica: Selling At Cash Value

ANGN - Angion Biomedica: Selling At Cash Value

Angion Biomedica Corp.
  • Angion Biomedica Corp was the fifth worst IPO of 2021, down over 80% as its lead candidate failed one Phase 3 and two Phase 2 trials.
  • The company recently announced a pivot to its other clinical asset – a potential therapy for fibrotic diseases of the kidney and lungs.
  • Trading at a discount to cash but with no meaningful catalysts in 2022, the recent insider buying in Angion at least merited a deeper dive.
  • A full investment analysis follows in the paragraphs below.

For further details see:

Angion Biomedica: Selling At Cash Value
Stock Information
Company Name: Angion Biomedica Corp.
Stock Symbol: ANGN
Market: NASDAQ
Menu
ANGN ANGN Quote ANGN Short ANGN News ANGN Articles ANGN Message Board
Get ANGN Alerts

News, Short Squeeze, Breakout and More Instantly...